respiratory
COPD

Negative findings should not deter beta blocker use in COPD patients


Beta blockers should still be used in patients with COPD and cardiovascular disease despite a trial showing they do not reduce exacerbations in patients without cardiovascular indications, researchers say. Published in the NEJM, findings from the BLOCK COPD trial showed that metoprolol had no effect on the primary outcome of time until the first COPD ...

Already a member?

Login to keep reading.


OR
© 2019 the limbic